MedPath
NMPA Approval

Cinnarizine Tablets

国药准字H14023243

April 18, 2022

国药准字H14023243

Drug Information

桂利嗪片

片剂

25mg

化学药品

April 18, 2022

Company Information

Applicant Company

大同市开发区医药工业园区

Manufacturing Company

山西省大同经济技术开发区恒安街1378号A区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

桂利嗪片 - NMPA 批准文号 | MedPath